Published in AIDS Weekly, July 27th, 1998
The international study conducted in Argentina, Brazil and Canada, is the largest, controlled, hydroxyurea-based trial ever conducted and could provide an important treatment option to patients worldwide that should be further explored. These findings were reported at the 12th International AIDS Conference, held in Geneva, Switzerland, June 28 - July 3, 1998.
"Close to 80...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.